BRIEF-Scynexis receives orphan drug designation for SCY-078
May 13, 2016 at 08:25 AM EDT
* Scynexis Inc Receives orphan drug designation for SCY-078 for the treatment of invasive Candida infections
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.